Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication
Nrf2 对心力衰竭氧化应激和囊泡外通讯的调节
基本信息
- 批准号:10593887
- 负责人:
- 金额:$ 64.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAnti-Inflammatory AgentsAntioxidantsAreaAttenuatedBrainCardiacCardiovascular systemCellsCentral Nervous SystemCirculationCommunicationCongestive Heart FailureCytosolDataDown-RegulationEnzymesEquilibriumErythroidExtracellular SpaceFibroblastsFunctional disorderGoalsHeartHeart failureHomeostasisHumanImpairmentInterventionKnowledgeMediatingMediatorMembraneMessenger RNAMicroRNAsModelingMolecularMorbidity - disease rateMusMuscle CellsMyocardialMyocardial InfarctionMyocardiumMyofibroblastNerveNeural PathwaysNuclearOrganOxidation-ReductionOxidative RegulationOxidative StressParacrine CommunicationPathogenesisPathologicPathologic ProcessesPathway interactionsPatientsPhenotypePhysiological ProcessesProcessProteinsRattusReactive Oxygen SpeciesRegulationReporterResearchRodentSignal TransductionSurfaceTechniquesTherapeutic UsesTimeTranslational RepressionTranslationsUbiquitinationantioxidant enzymeblood-brain barrier crossingcirculating microRNAclinically relevantextracellular vesicleshuman tissueinhibitorinnovationintercellular communicationmortalitynovelnovel therapeuticsoxidative damagetherapeutic miRNAtranscription factorvesicle transportvesicular release
项目摘要
PROJECT SUMMARY/ABSTRACT
Despite progress in the management of chronic heart failure (CHF), it remains a leading cause of mortality and
morbidity worldwide. A reduction in Nrf2 signaling has been closely associated with oxidative stress-mediated
cardiac remodeling and sympathetic excitation in the pathogenesis of CHF. However, there are several critical
gaps in our current knowledge of the molecular mechanisms of Nrf2 signaling dysregulation and cross-talk
between the heart and brain in CHF. Here our long-term goal is to understand a unique mechanism by which
Nrf2 signaling is impaired through intra- and inter-organ communication in CHF. In previous studies we showed
the potential involvement of miRNAs and extracellular vesicles (EVs) in Nrf2 dysregulation in CHF. EV-enriched
miRNAs have recently emerged as regulators of intercellular communication and paracrine signaling mediators
during physiological and pathological processes in the cardiovascular system. These findings led to the central
hypothesis that myocardial infarction (MI) induces the preferential secretion of miRNA-enriched EVs from cardiac
cells into the extracellular space where EV-miRNAs either directly contribute to increased local oxidative stress
via intercellular communication, or circulate to the CNS evoking sympathetic excitation by disrupting central
redox homeostasis due to a reduction in Nrf2 signaling. We have identified several miRNAs that target Nrf2
mRNA and are selectively upregulated in cardiac cells and contained in EVs that are secreted into the
extracellular space. We also provide evidence that cardiac-derived EVs and Nrf2-targeting miRNAs are present
in sympatho-regulatory areas of the brain. Guided by this strong preliminary data, we propose to pursue three
Specific Aims: 1) To determine if EV-enriched miRNAs contribute to Nrf2 translational inhibition and redox
imbalance through intercellular communication in the heart in the CHF state; 2) To determine if cardiac derived
EVs participate in inter-organ communication, especially cross-talk between the heart and brain in the
progression of CHF, and 3) To determine if circulating EVs from CHF animals transfer a pathophysiological
phenotype in sympatho-regulatory areas of the brain. This aim will also evaluate if EV-mediated miRNA inhibitor
delivery (i.e. antagomirs) attenuates the CHF phenotype by inhibition of the decrease in Nrf2 and antioxidant
enzyme signaling. Collectively, the proposed research is innovative because it pursues the novel idea that
miRNA-enriched EVs contribute to increased oxidative stress at the local level and in remote sympatho-
regulatory areas of the brain via EV-mediated communication by disrupting redox homeostasis in the CHF state.
This novel communication pathway may help to explain how sympathetic nerve activity increases in the post MI
state independent of classical neural pathways. Incorporation of human tissue into these studies will provide a
unique translational component and potentially lead to new therapies and interventions in CHF.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changhai Tian其他文献
Changhai Tian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changhai Tian', 18)}}的其他基金
Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication
Nrf2 对心力衰竭氧化应激和囊泡外通讯的调节
- 批准号:
10209606 - 财政年份:2021
- 资助金额:
$ 64.19万 - 项目类别:
Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication
Nrf2 对心力衰竭氧化应激和囊泡外通讯的调节
- 批准号:
10371159 - 财政年份:2021
- 资助金额:
$ 64.19万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 64.19万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 64.19万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 64.19万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 64.19万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 64.19万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 64.19万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 64.19万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 64.19万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 64.19万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 64.19万 - 项目类别: